Rethinking GLP-1RA Therapy Through the Lens of Glucagon and Resilience Published in Chemistry, Neuroscience, and General & Internal Medicine India Ambler and 2 others Why we wrote this commentary GLP-1 receptor agonists (GLP-1RAs) have transformed metabolic medicine
A current drawback of intracellular roGFP2-based mechanistic studies is, however, that the mechanisms and structure-function relationships still have to be validated in vitro
The plausible timeline, reconstructed from Lilly's disclosed trial schedule and standard regulatory review windows, looks roughly like this: Q2-Q3 2026: TRIUMPH-1 and TRIUMPH-2 readouts
Coverage: Klang Valley and major cities across Malaysia
Smaller dose-finding work (Falutz et al., PMID 22298602 review) established that lower doses produced proportionally lower visceral-fat reduction and lower IGF-1 elevation
Clients following more advanced glow-focused routines may incorporate higher serving amounts (8-15ml of Glutathione and 10ml of Vitamin C) as part of their wider corrective skincare protocol